FDA Import Refusal AEK-4913728-2/41/1 — Exemed Pharmaceuticals
The FDA refused shipment AEK-4913728-2/41/1 from Exemed Pharmaceuticals (India) on Mar 23, 2024. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Mar 23, 2024
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PDY70 DAPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75